|
|
||||||||
INVITED REVIEWS |
Nephrology,1 Department of Internal Medicine, Erasmus Medical Center, Rotterdam; Department of Nephrology,2 University Medical Center, Utrecht, The Netherlands
Correspondence to: M.W.J.A. Fieren, Erasmus Medical Center, Room Bd 336, Post office Box 2040, 3000CA Rotterdam, The Netherlands. m.fieren{at}erasmusmc.nl
Encapsulating peritoneal sclerosis (EPS) is a rare but serious
complication in patients on peritoneal dialysis (PD). We describe a cluster of
13 EPS cases occurring in 2 university hospitals in The Netherlands. Most of
these cases were diagnosed after recent kidney transplantation, when the
patients developed severe symptoms of bowel obstruction. This accumulation
raised the question as to whether other than known risk factors, such as
duration of PD treatment, could be involved in the development or course of
EPS after transplantation. According to various publications, EPS has been
diagnosed often after withdrawal from PD, suggesting that cessation in itself
may be a risk factor. In addition, transplantation-related management should
be considered to play a role, including the use of the profibrotic calcineurin
inhibitors and the trend to reduce the load of corticosteroids in treatment
regimes. To identify risk factors, further multicenter studies are required,
paying special attention to alterations in immunosuppressive treatment
regimens as well as PD prescriptions, including PD fluid characteristics.
Transfer from PD to hemodialysis should be under serious consideration in
patients eligible for kidney transplantation as soon as there are indications
of ultrafiltration failure.
KEY WORDS: Encapsulating peritoneal sclerosis; kidney transplantation; immunosuppressives; ultrafiltration failure.
Received 13 October 2006; accepted 20 July 2007.
This article has been cited by other articles:
![]() |
D. de Freitas, T. Augustine, H. Hurst, P. Taylor, R. Williams, A. Hutchison, P. E. C. Brenchley, and A. M. Summers Encapsulating peritoneal sclerosis following renal transplantation despite tamoxifen and immunosuppressive therapy NDT Plus, August 8, 2008; (2008) sfn109v1. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |